ENTEROBIOTIX LIMITED
SC559230Research and experimental development on biotechnology
ENTEROBIOTIX LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for ENTEROBIOTIX LIMITED (SC559230), an active life sciences and medical technology company based in United Kingdom. Incorporated 2 Mar 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2023)
Cash in Bank
£7.36M
Net Assets
-£6.02M
Total Liabilities
£18.22M
Turnover
N/A
Employees
65
Debt Ratio
149%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 31 Dec Year End | 2022 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 5 funding rounds
Sign up to view complete fundraising history
Investors (7)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 6 | Jan 2019 | Series A, Seed |
| Investor 2 | Sept 2021 | Venture - Series Unknown, Series B, Series A |
| Investor 3 | Sept 2021 | Venture - Series Unknown, Series B, Series A |
See all 7 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 18 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (4)
Mark Bamforth
British,american
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Morag Bamforth
American
- Significant Influence Or Control
Mr Mark Bamforth
British,american
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
- Right To Appoint And Remove Directors
Morag Bamforth
American
- Significant Influence Or Control
James Roger Mcilroy
Ceased 10 Jan 2020
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 4 Jun 2026 | Confirmation Statement | Confirmation statement made on 19 Apr 2026 with updates | |
| 22 Apr 2026 | Officers | Appointment of Melissa Strange as director on 20 Apr 2026 | |
| 16 Apr 2026 | Capital | Allotment of shares (GBP 9,299.202) on 30 Mar 2026 | |
| 2 Apr 2026 | Resolution | Resolutions | |
| 2 Apr 2026 | Incorporation | Memorandum Articles |
Confirmation statement made on 19 Apr 2026 with updates
Appointment of Melissa Strange as director on 20 Apr 2026
Allotment of shares (GBP 9,299.202) on 30 Mar 2026
Resolutions
Memorandum Articles
Recent Activity
Latest Activity
Confirmation statement made on 19 Apr 2026 with updates
3 weeks ago on 4 Jun 2026
Appointment of Melissa Strange as director on 20 Apr 2026
2 months ago on 22 Apr 2026
Allotment of shares (GBP 9,299.202) on 30 Mar 2026
2 months ago on 16 Apr 2026
Resolutions
2 months ago on 2 Apr 2026
Memorandum Articles
2 months ago on 2 Apr 2026